It sounds like people are comparing "Dr Moro" with a friend looking for a loan. This is not a fair comparison. Unless you are an insider, one can only go by public releases to determine how credible the technology and business plan of Biocurex is.

I would love to see them succeed, but I am very concerned that Biocurex expects everyone to vote for potential MASSIVE dilution without explaining the game plan ahead of time via corporate update, thereby laying out critical elements such as:

• how money will be spent
• on which technology angles
• when potential revenue can be expected ...

In so doing, the price could have risen or at least been maintained at a higher level, thereby reducing the amount of dilution required.

By not doing so, one gets the feeling that there is something to hide.

And I am tired of the "we can't tell you anything because of confidentiality agreements" line. Perhaps you can't name companies, but surely you can state which product lines are likely the first income generators, and when and by what marketing angle (without naming partners if necessary).

I tried to politely ask this by phone and email, but did not get a satisfactory answer.

Perhaps we will see something of significance before the meeting, but I'd have to say I'm not optimistic at this point.

By the way, a true friend would keep communication channels open.